Addressing climate migration requires a radical recalibration of how we govern mobility, allocate resources, and define international responsibility.

That is why enterprises must investigate the AI-readiness of their data, regardless of their adoption journeys. In DBTA's latest webinar, Is Your Data Ready for GenAI? Why You Must Know!, John O'Brien ...

TIGIT靶点的研发困境不仅限于百济神州。全球范围内，TIGIT抗体的临床试验失败率较高，显示出该靶点在临床转化中的复杂性。尽管TIGIT在实验室阶段展现出阻断免疫抑制通路的潜力，但在真实世界的临床试验中，其疗效并未达到预期。这种理论与实践的割裂，反映了肿瘤免疫治疗从靶点选择到临床转化的系统性挑战。

4月3日， 百济神州 （SH688235）宣布停止TIGIT（一种免疫检查点蛋白）抗体Ociperlimab（欧司珀利单抗，BGB-A1217）作为肺癌潜在治疗方法的临床开发计划。

今年1月，罗氏在2024年报中宣布终止TIGIT抗体5项临床试验，只保留肝癌适应症的临床。去年12月，默沙东也宣布终止开发TIGIT抗体，加上此次百济神州终止开发TIGIT抗体肺癌临床，TIGIT的先驱几乎全部折戟。

Intelligent Data Management Cloud (IDMC) is getting a host of new AI features, although some of them are still only in ...

Informatica , an AI-powered enterprise cloud data management leader, today announced data management innovations designed to simplify and enhance enterprise-wide access to AI-ready data. These ...

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data ...

GRI-0621是一种口服小分子RAR-β/γ双激动剂，已在多种疾病模型中证明能改善纤维化，并在患者中改善肝功能检测和其他炎症和损伤标志物。该药物的受体选择性与早期研究中口服tazarotene观察到的毒性特征一致，这些研究包括超过1,700名患者接受长达一年的治疗。

Informatica (NYSE: INFA), an AI-powered enterprise cloud data management leader, today announced the appointment of Krish Vitaldevara as Executive Vice President and Chief Product Officer. Bringing ...

Theriva announced that a second Independent Data Monitoring Committee review of data from the VIRAGE Phase 2b clinical trial in newly-diagnosed ...

这家公司叫康宁杰瑞制药，是国内领先的生物制药公司，在研产品中有一款全球性首创药物，代号KN046，能治肺癌、乳腺癌、肝癌等10余种肿瘤，其中，最具潜力的应用是胰腺癌： ...